Iron Triangle Partners LP - Q2 2022 holdings

$771 Million is the total value of Iron Triangle Partners LP's 25 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 100.0% .

 Value Shares↓ Weighting
NVST ExitENVISTA HOLDINGS CORPORATION$0-300,000
-100.0%
-1.74%
SGEN ExitSEAGEN INC$0-130,000
-100.0%
-2.23%
GDRX ExitGOODRX HLDGS INC$0-1,089,677
-100.0%
-2.50%
ALGN ExitALIGN TECHNOLOGY INC$0-50,000
-100.0%
-2.59%
NSTG ExitNANOSTRING TECHNOLOGIES INC$0-722,395
-100.0%
-2.99%
ICUI ExitICU MED INC$0-136,313
-100.0%
-3.61%
MOH ExitMOLINA HEALTHCARE INC$0-100,000
-100.0%
-3.97%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-190,073
-100.0%
-4.06%
HOLX ExitHOLOGIC INC$0-480,000
-100.0%
-4.39%
ILMN ExitILLUMINA INC$0-110,000
-100.0%
-4.57%
NVRO ExitNEVRO CORP$0-562,833
-100.0%
-4.84%
CTLT ExitCATALENT INC$0-392,663
-100.0%
-5.18%
UNH ExitUNITEDHEALTH GROUP INC$0-90,014
-100.0%
-5.46%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
HORIZON THERAPEUTICS PUB LTD12Q3 20229.0%
GUARDANT HEALTH INC12Q3 20226.1%
CHARLES RIV LABS INTL INC11Q1 20237.8%
SURGERY PARTNERS INC11Q2 20236.4%
ICON PLC10Q3 202311.7%
BOSTON SCIENTIFIC CORP10Q3 20238.9%
NEVRO CORP10Q1 20226.7%
DEXCOM INC10Q3 20237.7%
ABBVIE INC9Q3 20238.1%
ACADIA HEALTHCARE COMPANY IN9Q3 20237.9%

View Iron Triangle Partners LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View Iron Triangle Partners LP's complete filings history.

Compare quarters

Export Iron Triangle Partners LP's holdings